Putin said the vaccine is very effective, can form stable immunity and has passed all tests. The vaccine should be mass produced in the shortest possible time. Vaccination should be voluntary. In addition, Putin also revealed that his daughter had been vaccinated with the vaccine. After the vaccination, “her temperature rose to 38 degrees, slightly higher than 37 degrees the next day, that’s all.”. According to the news agency of Russia, the vaccine has been named “satellite-v” (sputnikv). According to sources, in 1957, the Soviet Union launched the first man-made earth satellite, Satellite-1, to strengthen space exploration worldwide. Russia’s new coronavirus vaccine has created a “satellite moment” for the whole world. According to this analogy, it is named “satellite-v”. According to the website of the Russian Ministry of health, the vaccine is a human adenovirus vector vaccine developed by the National Research Center for epidemiology and microbiology of gamaliya. The so-called adenovirus vector vaccine is to use the innocuous adenovirus after transformation as the carrier, and insert the S protein gene of the new coronavirus to make the adenovirus vector vaccine to stimulate the human body to produce antibodies. S protein is the key of new coronavirus invading human cells. Innocuous adenovirus puts on the “hat” of S protein and pretends to be “fierce” so that the human body can produce immune memory. This is a mature vaccine technology route. There are also some shortcomings in the vaccine of this technical route, and the research and development of recombinant virus vector vaccine needs to consider how to overcome the “pre-existing immunity”. Take the recombinant new crown vaccine which has entered the clinical trial as an example. The vaccine uses adenovirus type 5 as the vector, but most people have been infected with adenovirus type 5 during their growth. There may be antibodies in the body that can neutralize the adenovirus vector, which may attack the vector and reduce the effect of the vaccine. In other words, the safety of the vaccine is high, but the effectiveness may be insufficient. According to the website of the Russian Ministry of health, the vaccine has previously passed a variety of animal tests (rodents and primates) and clinical trials of two groups of volunteers (38 people in each group). The vaccine contains no new coronavirus components, and can form long-term immunity through two vaccination. According to the experience of using vector vaccine, immunity can last up to 2 years. It is not difficult to see that “satellite-v” vaccine can make people produce antibodies. But the vaccine has only been tested on less than 100 people, and the third phase of testing (large-scale clinical trials) has not yet been completed. The third phase test is very important for vaccine development, because only through large-scale clinical trials can we find some unusual side effects. < / P > < p > so why has the Russian Ministry of Health approved the registration of vaccines? According to the Russian news agency, Russian health minister murashko previously disclosed that the third phase of the test will be carried out at the same time as the vaccine is put into civilian circulation. In other words, Russia adopts the method of “observing while using”. < / P > < p > regarding the practice of the Russian Ministry of health, the Russian Association of clinical research organizations has written to the Ministry of health, hoping to pass the registration of vaccine after the third stage test. In response, the chief epidemiologist of the Russian Ministry of health briko said that the research and development technology of Russia’s new coronavirus vaccine has been applied in other vaccine research and development, so there is no need to delay the registration. In addition, brico revealed that in his view, the safety of the vaccine has been verified, and further study on its effectiveness will be carried out. Dmitry riev, President of Russia’s Direct Investment Fund (vaccine cooperative manufacturer), revealed on the 11th that the third phase of the test will be launched on August 12, and the test data will be released immediately after it is available. According to murashko, the vaccine will be produced at the National Research Center for epidemiology and microbiology of gamaliya and binnopharm, a Russian vaccine manufacturer. Russian Deputy Prime Minister gorikova said that it is hoped that the first batch of vaccinations will be made by medical personnel. According to the Russian national drug registration network, the time when the vaccine officially entered the field of civil circulation was January 1, 2021. < / P > < p > for other countries, dmitryev revealed that the fund and partners have invested 4 billion rubles in the production of new coronavirus vaccine in Russia. At present, more than 1 billion applications for new coronavirus vaccines have been received from more than 20 countries. < / P > < p > according to dimitriev’s earlier disclosure, the vaccine production will reach 200 million by the end of 2020, of which 30 million will be produced by Russia, and the rest will be produced with the help of partner countries. By 2021, vaccine production will reach 3 billion, which can help the world fight the epidemic.